David Apelian
2013 - Achillion Pharmaceuticals
In 2013, David Apelian earned a total compensation of $2.2M as Executive Vice President and Chief Medical Officer at Achillion Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $100,100 |
|---|---|
| Option Awards | $1,807,634 |
| Salary | $256,667 |
| Other | $10,726 |
| Total | $2,175,127 |
Apelian received $1.8M in option awards, accounting for 83% of the total pay in 2013.
Apelian also received $100.1K in non-equity incentive plan, $256.7K in salary and $10.7K in other compensation.
Rankings
In 2013, David Apelian's compensation ranked 3,619th out of 12,286 executives tracked by ExecPay. In other words, Apelian earned more than 70.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,619 out of 12,286 | 71st |
Division Manufacturing | 1,226 out of 4,612 | 73rd |
Major group Chemicals And Allied Products | 333 out of 1,462 | 77th |
Industry group Drugs | 233 out of 1,156 | 80th |
Industry Pharmaceutical Preparations | 191 out of 890 | 79th |
Source: SEC filing on April 15, 2016.
Apelian's colleagues
We found five more compensation records of executives who worked with David Apelian at Achillion Pharmaceuticals in 2013.
2013
Milind Deshpande
Achillion Pharmaceuticals
Chief Executive Officer
2013
Mary Fenton
Achillion Pharmaceuticals
Chief Financial Officer
2013
Joseph Truitt
Achillion Pharmaceuticals
Executive Vice President and Chief Commercial Officer
2013
Gautam Shah
Achillion Pharmaceuticals
Former Executive Vice President and Chief Compliance Officer
2013
Michael Kishbauch
Achillion Pharmaceuticals